IL33 and cancer: Our immunohistochemical analysis revealed that the protein expression levels of IL-33 are significantly higher in cancers than those in adjacent non-cancerous tissues (Fig. 3B, C) and higher IL-33 expression in tumors significantly correlates with shorter five- year survival of patients (Fig. 3D).